The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Neuropsychological Measures in Normal Individuals That Predict Subsequent Cognitive Decline
Abstract
OBJECTIVE: To examine neuropsychological measures among normal individuals that predict time to subsequent cognitive decline. DESIGN: Cognitive performance, as measured by 6 neuropsychological tests, was examined at baseline. Participants were followed up for approximately 5 years. Cox proportional hazards models were used to evaluate the neuropsychological measures at baseline that predicted time to progression from normal cognition to mild impairment. Comparable data also examined time to progression from mild impairment to a diagnosis of Alzheimer disease. SETTING: Community volunteer-based sample examined at a medical institution. PARTICIPANTS: One hundred and seven individuals who were cognitively normal and 235 individuals with mild cognitive impairment at baseline. MAIN OUTCOME MEASURES: Time to progression from normal cognition to mild impairment and time to progression from mild impairment to a diagnosis of Alzheimer disease. RESULTS: The risk of progressing from normal to mild impairment was considerably greater among those with lower scores on tests of episodic memory (eg, hazard ratio for a 1-SD decrease in the California Verbal Learning Test, 0.55; P<.001). Normal individuals who carried at least 1 copy of the apolipoprotein E epsilon2 allele were less likely to develop cognitive impairments over time than individuals with no epsilon2 allele (hazard ratio for presence of allele, 0.13; P = .006). Measures of both episodic memory and executive function were significant predictors of time to progression from mild impairment to a clinical diagnosis of Alzheimer disease (eg, hazard ratio for a 1-SD decrease in California Verbal Learning Test score, 0.67; P = .005; hazard ratio for a 1-SD increase in the time to complete part B of the Trail Making test, 1.40; P = .007). Among individuals with mild impairments, the apolipoprotein E epsilon4 allele increased risk for Alzheimer disease in a dose-dependent manner; however, this effect was not significant within the context of multivariable models. CONCLUSIONS: Episodic memory performance among normal individuals predicts time to progression to mild impairment while apolipoprotein E epsilon2 status is associated with lower risk of cognitive decline among normal individuals. Tests of both episodic memory and executive function are predictors of time to progression from mild impairment to a clinical diagnosis of Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Petersen, R. C., Thomas, R. G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050151 · Cited by 1,844
McKhann, G. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1803 · Cited by 1,472
Checking the Cox model with cumulative sums of martingale-based residuals
LIN, D. Y., WEI, L. J., & YING, Z. (1993) · Biometrika · doi:10.1093/biomet/80.3.557 · Cited by 1,432
Neuropathology of older persons without cognitive impairment from two community-based studies
Bennett, D. A., Schneider, J. A., Arvanitakis, Z., Kelly, J. F., Aggarwal, N. T., Shah, R. C., & Wilson, R. S. (2006) · Neurology · doi:10.1212/01.wnl.0000219668.47116.e6 · Cited by 1,336
California Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (2016) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,319
Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man
Petrides, M., & Milner, B. (1982) · Neuropsychologia · doi:10.1016/0028-3932(82)90100-2 · Cited by 1,274
Dorsal anterior cingulate cortex: A role in reward-based decision making
Bush, G., Vogt, B. A., Holmes, J., Dale, A. M., Greve, D., Jenike, M. A., & Rosen, B. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012470999 · Cited by 1,096
Multilingual Aphasia Examination
Patterson, J. P. (2018) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-57111-9_900 · Cited by 1,096
Genuine memory deficits in dementia
Grober, E., & Buschke, H. (1987) · Developmental Neuropsychology · doi:10.1080/87565648709540361 · Cited by 1,047
Natural history of mild cognitive impairment in older persons
Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., & Bach, J. (2002) · Neurology · doi:10.1212/wnl.59.2.198 · Cited by 1,037
Petersen, R. C. (2016) · Continuum · doi:10.1212/con.0000000000000313 · Cited by 909
Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis
Bäckman, L., Jones, S., Berger, A.-K., Laukka, E. J., & Small, B. J. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.4.520 · Cited by 735
Neuropathology of Cognitively Normal Elderly
Knopman, D. S., Parisi, J. E., Salviati, A., Floriach-Robert, M., Boeve, B. F., Ivnik, R. J., Smith, G. E., Dickson, D. W., Johnson, K. A., Petersen, L. E., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.11.1087 · Cited by 674
Tierney, M. C., Szalai, J. P., Snow, W. G., Fisher, R. H., Nores, A., Nadon, G., Dunn, E., & St. George-Hyslop, P. H. (1996) · Neurology · doi:10.1212/wnl.46.3.661 · Cited by 575
Attentional Control in the Aging Brain: Insights from an fMRI Study of the Stroop Task
Milham, M. P., Erickson, K. I., Banich, M. T., Kramer, A. F., Webb, A., Wszalek, T., & Cohen, N. J. (2002) · Brain and Cognition · doi:10.1006/brcg.2001.1501 · Cited by 549
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A., & Wilson, R. S. (2005) · Neurology · doi:10.1212/01.wnl.0000152982.47274.9e · Cited by 537
Preclinical prediction of AD using neuropsychological tests
ALBERT, M. S., MOSS, M. B., TANZI, R., & JONES, K. (2001) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617701755105 · Cited by 519
Self-citationA Functional Account of Age Differences in Memory
Craik (2016) · doi:10.4324/9781315440446-15 · Cited by 491
Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons
Masur, D. M., Sliwinski, M., Lipton, R. B., Blau, A. D., & Crystal, H. A. (1994) · Neurology · doi:10.1212/wnl.44.8.1427 · Cited by 422
Neuropsychological detection and characterization of preclinical Alzheimer’s disease
Jacobs, D. M., Sano, M., Dooneief, G., Marder, K., Bell, K. L., & Stern, Y. (1995) · Neurology · doi:10.1212/wnl.45.5.957 · Cited by 409
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2000) · Neurology · doi:10.1212/wnl.55.12.1847 · Cited by 397
“Preclinical” AD revisited: Neuropathology of cognitively normal older adults
Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000) · Neurology · doi:10.1212/wnl.55.3.370 · Cited by 369
Patterns of Cognitive Decline in Presymptomatic Alzheimer Disease: A Prospective Community Study
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.853 · Cited by 369
Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information
Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.5.675 · Cited by 360
Self-citationMemory function in very early Alzheimer's disease
Petersen, R. C., Smith, G. E., Ivnik, R. J., Kokmen, E., & Tangalos, E. G. (1994) · Neurology · doi:10.1212/wnl.44.5.867 · Cited by 337
A Prospective Study of Cognitive Function and Onset of Dementia in Cognitively Healthy Elders
Rubin, E. H., Storandt, M., Miller, J. P., Kinscherf, D. A., Grant, E. A., Morris, J. C., & Berg, L. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.395 · Cited by 317
HULETTE, C. M., WELSH-BOHMER, K. A., MURRAY, M. G., SAUNDERS, A. M., MASH, D. C., & MCINTYRE, L. M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00009 · Cited by 311
Morrison, J. H., & Hof, P. R. (2002) · Progress in Brain Research · doi:10.1016/s0079-6123(02)36039-4 · Cited by 242
Neuropsychological Prediction of Decline to Dementia in Nondemented Elderly
Kluger, A., Ferris, S. H., Golomb, J., Mittelman, M. S., & Reisberg, B. (1999) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879901200402 · Cited by 227
Cognitive Markers Preceding Alzheimer's Dementia in the Healthy Oldest Old
Howieson, D. B., Dame, A., Camicioli, R., Sexton, G., Payami, H., & Kaye, J. A. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb03091.x · Cited by 210
Defining Molecular Targets to Prevent Alzheimer Disease
Selkoe, D. J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.2.192 · Cited by 169
Preclinical cognitive markers of dementia of the Alzheimer type.
Bondi, M. W., Monsch, A. U., Galasko, D., & Butters, N. (1994) · Neuropsychology · doi:10.1037//0894-4105.8.3.374 · Cited by 163
The apolipoprotein E varepsilon2 allele and decline in episodic memory
Wilson, R. S. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.6.672 · Cited by 161
Absence of cognitive impairment or decline in preclinical Alzheimer’s disease
Goldman, W. P., Price, J. L., Storandt, M., Grant, E., McKeel, D. W., Rubin, E. H., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.3.361 · Cited by 150
Longitudinal changes in verbal memory in older adults
Lamar, M., Resnick, S. M., & Zonderman, A. B. (2003) · Neurology · doi:10.1212/wnl.60.1.82 · Cited by 128
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Predictors of cognitive change in middle-aged and older adults with memory loss
Small, G. W., Rue, A. L., Komo, S., Kaplan, A. R., & Mandelkern, M. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1757 · Cited by 116
Conceptualization of mild cognitive impairment: a review
Davis, H. S., & Rockwood, K. J. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1049 · Cited by 110
Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals
Lin, D. Y., Wei, L. J., & Ying, Z. (1993) · Biometrika · doi:10.2307/2337177 · Cited by 103
Cued Recall and Early Identification of Dementia
Tuokko, H. A., Vernon-Wilkinson, R., Weir, J., & Beattie, B. L. (1991) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639108405104 · Cited by 99
Newman, S., Warrington, E. K., Kennedy, A. M., & Rossor, M. N. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.967 · Cited by 65
Longitudinal Models of Growth and Survival Applied to the Early Detection of Alzheimer’s Disease
McArdle, J. J., Small, B. J., Bäckman, L., & Fratiglioni, L. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281879 · Cited by 54
Self-citationPetersen, R. C. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293545.39683.cc · Cited by 54
Vitamin E and donepezil for the treatment of mild cognitive impairment
Marder, K. S. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0056-6 · Cited by 35
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented
Tierney, M. C. (2001) · Neurology · doi:10.1212/wnl.57.1.163 · Cited by 26
Cited by
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Effects of Aerobic Exercise on Mild Cognitive Impairment: A Controlled Trial
Baker, L. D., Frank, L. L., Foster-Schubert, K., Green, P. S., Wilkinson, C. W., McTiernan, A., Plymate, S. R., Fishel, M. A., Watson, G. S., Cholerton, B. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.307 · Cited by 1,171
Comparing predictors of conversion and decline in mild cognitive impairment
Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e8e8b8 · Cited by 616
Caloric restriction improves memory in elderly humans
Witte, A. V., Fobker, M., Gellner, R., Knecht, S., & Flöel, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808587106 · Cited by 574
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Metadata
- Authors
- Blacker, D., Lee, H., Muzikansky, A., Martin, E. C., Tanzi, R., McArdle, J. J., Moss, M., & Albert, M.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-06-01
- Volume
- 64
- Issue
- 6
- Pages
- 862
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2158683061
- Cited by
- 261
- References
- 58
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.